SAGE Sage Therapeutics Inc

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Monday, August 7, 2023 at 8:00 a.m. ET to provide a business update. Second quarter 2023 financial results will also be announced on Monday, August 7.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230804198322/en/

Investor Ashley Kaplowitz 786-252-1419 ashley.kaplowitz@sagerx.com

Media Matthew Henson 917-930-7147 matthew.henson@sagerx.com

Sage Therapeutics (NASDAQ:SAGE)
過去 株価チャート
から 4 2024 まで 5 2024

Sage Therapeutics (NASDAQ:SAGE)
過去 株価チャート
から 5 2023 まで 5 2024